MindMed to Participate in May Investor Conferences
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) has announced participation in two upcoming investor conferences.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
-
H.C. Wainwright BioConnect Conference - Format: 1x1 Investor Meetings
-
Date:
Tuesday, May 2, 2023
-
RBC Capital Markets Global Healthcare Conference - Format: Fireside Chat
-
Date and Time:
Wednesday, May 17 at4:35 pm EDT -
Webcast Link:
RBC Capital Markets Global Healthcare Conference
Audio webcasts and replays of available presentations will be accessible on MindMed’s Investor Resources website for up to 90 days following each event.
About MindMed
MindMed is a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders. Our mission is to be the global leader in the development and delivery of treatments that unlock new opportunities to improve patient outcomes. We are developing a pipeline of innovative product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways that play key roles in brain health disorders.
MindMed trades on NASDAQ under the symbol MNMD and on the Canadian
View source version on businesswire.com: https://www.businesswire.com/news/home/20230426005249/en/
For Media & Investor Inquiries, please contact:
Vice President, Investor Relations and Corporate Communications
ir@mindmed.co
media@mindmed.co
Source: MindMed